Skip Navigation


NDT Advance Access originally published online on April 19, 2005
Nephrology Dialysis Transplantation 2005 20(6):1274; doi:10.1093/ndt/gfh852
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/6/1274-a    most recent
gfh852v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bachmeyer, C.
Right arrow Articles by Demontis, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bachmeyer, C.
Right arrow Articles by Demontis, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Letter

Rituximab is an alternative in a case of contra-indication of cyclophosphamide in Wegener's granulomatosis

The first 10% of the full text of this article appears below.

Sir,

We read with interest the report by Ferraro et al. [1] on the effectiveness of rituximab in refractory Wegener's granulomatosis (WG). We report . . . [Full Text of this Article]

Claude Bachmeyer1, Jean-François Cadranel2 and Renato Demontis3

1 Service de Médecine Interne CHU Tenon Paris France2 Unité d'Hépatogastroentérologie3 Service de Néphrologie Hôpital Laennec Creil France Email: claude.bachmeyer@tnn.ap-hp-paris.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann Rheum DisHome page
D E Furst, F C Breedveld, J R Kalden, J S Smolen, G R Burmester, J Sieper, P Emery, E C Keystone, M H Schiff, P Mease, et al.
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007
Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii2 - iii22.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. A. Keogh, S. R. Ytterberg, F. C. Fervenza, K. A. Carlson, D. R. Schroeder, and U. Specks
Rituximab for Refractory Wegener's Granulomatosis: Report of a Prospective, Open-Label Pilot Trial
Am. J. Respir. Crit. Care Med., January 15, 2006; 173(2): 180 - 187.
[Abstract] [Full Text] [PDF]